p.69 抽出テキスト

Lawton et al 2021 ACC/AHA/SCAI Coronary Revascularization Guideline

January 18, 2022 Circulation. 2022;145:e18–e114. DOI: 10.1161/CIR.0000000000001038 e86

CLINICAL STATEMENTS AND GUIDELINES 15.	 Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after

fibrinolysis for acute myocardial infarction. N Engl J Med. 2009;360:2705– 2718. 16.	 Di Mario C, Dudek D, Piscione F, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CA- RESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet. 2008;371:559–568. 17.	 Borgia F, Goodman SG, Halvorsen S, et al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J. 2010;31:2156– 2169. 18.	 Armstrong PW, WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J. 2006;27:1530–1538. 19.	 Fernandez-Avilés F, Alonso JJ, Castro-Beiras A, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRA- CIA-1): a randomised controlled trial. Lancet. 2004;364:1045–1053. 20.	 Le May MR, Wells GA, Labinaz M, et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J Am Coll Cardiol. 2005;46:417–424. 21.	 Schömig A, Mehilli J, Antoniucci D, et al. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA. 2005;293:2865–2872. 22.	 Gierlotka M, Gasior M, Wilczek K, et al. Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]). Am J Cardiol. 2011;107:501– 508. 23.	 Pi Y, Roe MT, Holmes DN, et al. Utilization, characteristics, and in-hospital outcomes of coronary artery bypass grafting in patients with ST-segmentelevation myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry—Get With The Guidelines. Circ Cardiovasc Qual Outcomes. 2017;10:e003490. 24.	 Grothusen C, Friedrich C, Loehr J, et al. Outcome of stable patients with acute myocardial infarction and coronary artery bypass surgery within 48 hours: a single-center, retrospective experience. J Am Heart Assoc. 2017;6: e005498. 25.	 Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355:2395– 2407. 26.	 Steg PG, Thuaire C, Himbert D, et al. DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J. 2004;25:2187–2194. 27.	 Mehta RH, Grab JD, O’Brien SM, et al. Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the Society of Thoracic Surgeons National Cardiac Database. Circulation. 2008;117:876–885. 28.	 Acharya D, Gulack BC, Loyaga-Rendon RY, et al. Clinical characteristics and outcomes of patients with myocardial infarction and cardiogenic shock undergoing coronary artery bypass surgery: data from the Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2016;101:558–566. 29.	 Santarpino G, Ruggieri VG, Mariscalco G, et al. Outcome in patients having salvage coronary artery bypass grafting. Am J Cardiol. 2015;116:1193– 1198. 30.	 Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation. 2006;114:2019–2025. 31.	 Armstrong PW, Gershlick AH, Goldstein P, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013;368:1379– 1387. 32.	 Braxton JH, Hammond GL, Letsou GV, et al. Optimal timing of coronary artery bypass graft surgery after acute myocardial infarction. Circulation. 1995;92:II66–II68. 33.	 Tavakoli R, Weber A, Brunner-La Rocca H, et al. Results of surgery for irreversible moderate to severe mitral valve regurgitation secondary to myocardial infarction. Eur J Cardiothorac Surg. 2002;21:818–824. 34.	 Shamshad F, Kenchaiah S, Finn PV, et al. Fatal myocardial rupture after

acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VAL- IANT) Am Heart J. 2010;160:145–151. 35 Schroeter T, Lehmann S, Misfeld M, et al. Clinical outcome after mitral

valve surgery due to ischemic papillary muscle rupture. Ann Thorac Surg. 2013;95:820–824. 36.	 Arnaoutakis GJ, Zhao Y, George TJ, et al. Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2012;94:436–443. discussion 43-4. 37.	 Singh V, Rodriguez AP, Bhatt P, et al. Ventricular septal defect complicating ST-elevation myocardial infarctions: a call for action. Am J Med. 2017;130:863.e1–863.e12. 38.	 Lanz J, Wyss D, Räber L, et al. Mechanical complications in patients with STsegment elevation myocardial infarction: a single centre experience. PLoS One. 2019;14: e0209502. 39.	 Wan Y-D, Sun T-W, Kan Q-C, et al. The effects of intra-aortic balloon pumps on mortality in patients undergoing high-risk coronary revascularization: a meta-analysis of randomized controlled trials of coronary artery bypass grafting and stenting era. PLoS One11;2016, e0147291. 40.	 Kettner J, Sramko M, Holek M, et al. Utility of intra-aortic balloon pump support for ventricular septal rupture and acute mitral regurgitation complicating acute myocardial infarction. Am J Cardiol. 2013;112:1709–1713. 41.	 Mason PJ, Shah B, Tamis-Holland JE, et al. An update on radial artery access and best practices for transradial coronary angiography and intervention in acute coronary syndrome: a scientific statement from the American Heart Association. Circ Cardiovasc Interv. 2018;11:e000035. 42.	 D’Souza SP, Mamas MA, Fraser DG, et al. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute STelevation myocardial infarction: a meta-analysis. Eur Heart J. 2011;32:972– 982. 43.	 Ndrepepa G, Kastrati A, Mehilli J, et al. Mechanical reperfusion and long-

term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms. JAMA. 2009;301:487–488.

5.2 Revascularization of the Non-Infarct Artery in Patients With STEMI

1.	 Politi L, Sgura F, Rossi R, et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up. Heart. 2010;96:662– 667. 2.	 Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65:963–972. 3.	 Engstrom T, Kelbaek H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386:665–671. 4.	 Mehta SR, Wood DA, Storey RF, et al. Complete revascularization with multivessel PCI for myocardial infarction. N Engl J Med. 2019;381:1411–1421. 5.	 Di Mario C, Mara S, Flavio A, et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent. 2004;6:128–133. 6.	 Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med. 2013;369:1115–1123. 7.	 Smits PC, Abdel-Wahab M, Neumann FJ, et al. Fractional flow reserveguided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376:1234–1244. 8.	 Thiele H, Akin I, Sandri M, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377:2419–2432. 9.	 Thiele H, Akin I, Sandri M, et al. One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med. 2018;379:1699–1710. 10.	 Kolte D, Sardar P, Khera S, et al. Culprit vessel-only versus multivessel percutaneous coronary intervention in patients with cardiogenic shock complicating ST-segment-elevation myocardial infarction: a collaborative metaanalysis. Circ Cardiovasc Interv. 2017;10:e005582. 11.	 Bates ER, Tamis-Holland JE, Bittl JA, et al. PCI strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease. J Am Coll Cardiol. 2016;68:1066–1081. 12.	 Wood DA, Cairns JA, Wang J, et al. Timing of staged nonculprit artery revascularization in patients with ST-segment elevation myocardial infarction: COMPLETE Trial. J Am Coll Cardiol. 2019;74:2713–2723. 13.	 Dehmer GJ, Badhwar V, Bermudez EA, et al. 2020 AHA/ACC key data

elements and definitions for coronary revascularization: a report of the

Downloaded from http://ahajournals.org by on October 7, 2026